Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Completed · Phase 2

Conditions studied: HIV Infections, Pregnancy

In brief

The purpose of this study is to examine the drug interactions between a protease inhibitor (PI)-based regimen including lopinavir/ritonavir (LPV/r) and two forms of contraceptive medications in HIV infected women.

Key facts

Study ID

NCT00125983

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

32

Expected to finish

2007-01-01

Last updated by the study team

2021-11-01

Who can join

Age: 13 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• USC CRS — Los Angeles, California, United States
• Usc La Nichd Crs — Los Angeles, California, United States
• University of Colorado Hospital CRS — Aurora, Colorado, United States
• Univ. of Hawaii at Manoa, Leahi Hosp. — Honolulu, Hawaii, United States
• Indiana Univ. School of Medicine, Infectious Disease Research Clinic — Indianapolis, Indiana, United States
• Beth Israel Med. Ctr., ACTU — New York, New York, United States
• Weill Med. College of Cornell Univ., The Cornell CTU — New York, New York, United States
• Pitt CRS — Pittsburgh, Pennsylvania, United States
• San Juan City Hosp. PR NICHD CRS — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.